Fierce Biotech

AstraZeneca keeps UK research site on pause, but options open

AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U.K. hometown, despite keeping its options open. | AstraZeneca is showing no signs of ...

AstraZeneca's plans for new Cambridge campus block

The company says the proposal will create space for hundreds of its staff to work at the campus.

Drugmakers AstraZeneca, GSK to join Starmer delegation to China, sources say

By Andrew MacAskill, Maggie Fick and Bhanvi Satija LONDON, Jan 26 (Reuters) - UK-based drugmakers AstraZeneca and GSK will ...
Cambridge Independent

AstraZeneca keeps options open on Cambridge expansion with conference centre and office application

AstraZeneca is keeping its options over expansion in Cambridge open by submitting fresh plans for a new conference centre and ...
pharmaphorum

AstraZeneca pays $630m to get full control of AbelZeta CAR-T

To get full control of C-CAR031, AZ is buying out AbelZeta's 50% share of the China development and commercialisation rights ...
The Peninsula Qatar

UK drugs giant AstraZeneca says US listing starts February

London: British pharmaceutical giant AstraZeneca on Tuesday said trading of its shares on the New York Stock Exchange will start from February, in ...
Hosted on MSN

AstraZeneca exit: here’s what it really means for the UK

AstraZeneca Plc (LON: AZN) is in focus this morning following reports that its chief executive – Pascal Soriot is considering moving the giant’s listing to the US. The pharmaceutical behemoth’s ...